Fergusson D - Search Results

1

Design and Reporting of Targeted Anticancer Preclinical Studies: A Meta-Analysis of Animal Studies Investigating Sorafenib Antitumor Efficacy.

Mattina J, MacKinnon N, Henderson VC, Fergusson D, Kimmelman J. Mattina J, et al. Among authors: fergusson d. Cancer Res. 2016 Aug 15;76(16):4627-36. doi: 10.1158/0008-5472.CAN-15-3455. Epub 2016 Jun 3. Cancer Res. 2016. PMID: 27261504 Free PMC article.

2

Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments.

Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG. Henderson VC, et al. Among authors: fergusson d. PLoS Med. 2013;10(7):e1001489. doi: 10.1371/journal.pmed.1001489. Epub 2013 Jul 23. PLoS Med. 2013. PMID: 23935460 Free PMC article. Review.

3

Late, never or non-existent: the inaccessibility of preclinical evidence for new drugs.

Federico CA, Carlisle B, Kimmelman J, Fergusson DA. Federico CA, et al. Among authors: fergusson da. Br J Pharmacol. 2014 Sep;171(18):4247-54. doi: 10.1111/bph.12771. Epub 2014 Jul 2. Br J Pharmacol. 2014. PMID: 24825131 Free PMC article.

4

Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials.

Hakala A, Kimmelman J, Carlisle B, Freeman G, Fergusson D. Hakala A, et al. Among authors: fergusson d. BMJ. 2015 Mar 9;350:h1116. doi: 10.1136/bmj.h1116. BMJ. 2015. PMID: 25752879 Free article.

5

Elements of informed consent and decision quality were poorly correlated in informed consent documents.

Brehaut JC, Carroll K, Elwyn G, Saginur R, Kimmelman J, Shojania K, Syrowatka A, Nguyen T, Fergusson D. Brehaut JC, et al. Among authors: fergusson d. J Clin Epidemiol. 2015 Dec;68(12):1472-80. doi: 10.1016/j.jclinepi.2015.03.002. Epub 2015 Mar 7. J Clin Epidemiol. 2015. PMID: 25857675 Review.

6

A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib.

Henderson VC, Demko N, Hakala A, MacKinnon N, Federico CA, Fergusson D, Kimmelman J. Henderson VC, et al. Among authors: fergusson d. Elife. 2015 Oct 13;4:e08351. doi: 10.7554/eLife.08351. Elife. 2015. PMID: 26460544 Free PMC article.

7

Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review.

Mattina J, Carlisle B, Hachem Y, Fergusson D, Kimmelman J. Mattina J, et al. Among authors: fergusson d. PLoS Biol. 2017 Feb 3;15(2):e2000487. doi: 10.1371/journal.pbio.2000487. eCollection 2017 Feb. PLoS Biol. 2017. PMID: 28158308 Free PMC article. Review.

8

Nonpublication of trial results for new neurological drugs: A systematic review.

Hakala AK, Fergusson D, Kimmelman J. Hakala AK, et al. Among authors: fergusson d. Ann Neurol. 2017 Jun;81(6):782-789. doi: 10.1002/ana.24952. Epub 2017 Jun 5. Ann Neurol. 2017. PMID: 28486773 Review.

9

Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis.

Waligora M, Bala MM, Koperny M, Wasylewski MT, Strzebonska K, Jaeschke RR, Wozniak A, Piasecki J, Sliwka A, Mitus JW, Polak M, Nowis D, Fergusson D, Kimmelman J. Waligora M, et al. Among authors: fergusson d. PLoS Med. 2018 Feb 20;15(2):e1002505. doi: 10.1371/journal.pmed.1002505. eCollection 2018 Feb. PLoS Med. 2018. PMID: 29462168 Free PMC article.

10

Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications: A Systematic Review.

Federico CA, Wang T, Doussau A, Mogil JS, Fergusson D, Kimmelman J. Federico CA, et al. Among authors: fergusson d. JAMA Intern Med. 2019 Jan 1;179(1):90-97. doi: 10.1001/jamainternmed.2018.5705. JAMA Intern Med. 2019. PMID: 30477010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,193 results

Search Page

Filters